Lysine-Derived Carbon Dots for Chiral Inhibition of Prion Peptide Fibril Assembly

Elad Arad, Susanta Kumar Bhunia, Jürgen Jopp, Sofiya Kolusheva, Hanna Rapaport, Raz Jelinek

Research output: Contribution to journalArticlepeer-review

20 Scopus citations


The transmissible spongiform encephalopathies are a family of diseases characterized by abnormal folding and aggregation of the prion protein. One of the directions in the search for cure for these and other amyloid diseases focuses on the inhibition of protein aggregation by small molecules, short peptides, and nanoparticles. Nanoparticles seem to be particularly promising therapeutic candidates since they are stable, can be made biocompatible, and might readily traverse physiological barriers such as the blood–brain barrier. Here, a novel class of chiral amyloid inhibitors consisting of carbon quantum dots (C-dots) that are synthesized from either d- or l-lysine (Lys) as the sole carbonaceous building block are reported. The interactions of the chiral lys-C-dots with the amyloidogenic determinant of the prion peptide (PrP, 106–126 sequence) in the presence of lipid bilayers appears to be highly stereoselective, with the l-Lys-C-dots being superior to the d-Lys-C-dots in their ability to modulate the structural transformations and aggregation of PrP(106–126). This work provides new insights into chiral effects upon amyloid peptides and opens the way to developing chiral carbon-based nanostructures as advanced amyloid inhibitors.

Original languageEnglish
Article number1800006
JournalAdvanced Therapeutics
Issue number4
StatePublished - 1 Aug 2018


  • amyloid diseases
  • amyloid inhibitors
  • carbon dots
  • chiral nanoparticles
  • prion protein

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology
  • Pharmaceutical Science
  • Genetics(clinical)
  • Biochemistry, medical
  • Pharmacology (medical)


Dive into the research topics of 'Lysine-Derived Carbon Dots for Chiral Inhibition of Prion Peptide Fibril Assembly'. Together they form a unique fingerprint.

Cite this